COSCIENS Biopharma (CSCI) Q3 2024 Earnings

13AugConfirmed
Q2 2024
Q3 2024
-4.74
-3.37
-2.01
-0.64

Details

Expected EPS
-3.28
Actual EPS
-0.64
Surprise EPS
2.64
Surprise Percent
+80.49%

Description

COSCIENS Biopharma (CSCI) has reported earnings of -0.64 per share for Q3 2024.

0 Comments

Share your thoughts